AU2002212241A1 - Method for producing chiral compounds - Google Patents
Method for producing chiral compoundsInfo
- Publication number
- AU2002212241A1 AU2002212241A1 AU2002212241A AU1224102A AU2002212241A1 AU 2002212241 A1 AU2002212241 A1 AU 2002212241A1 AU 2002212241 A AU2002212241 A AU 2002212241A AU 1224102 A AU1224102 A AU 1224102A AU 2002212241 A1 AU2002212241 A1 AU 2002212241A1
- Authority
- AU
- Australia
- Prior art keywords
- chiral compounds
- producing chiral
- compound
- pharmaceutical compositions
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/18—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by addition of thiols to unsaturated compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/16—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by addition of hydrogen sulfide or its salts to unsaturated compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
A method for producing chiral compounds according to the condition of a 1.4 Michael reaction, and a compound of formula (31). The invention also provides pharmaceutical compositions comprising the compound, and methods for treating pain and other diseases using the pharmaceutical compositions.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10045832 | 2000-09-14 | ||
| DE10045832A DE10045832A1 (en) | 2000-09-14 | 2000-09-14 | Process for the preparation of chiral compounds |
| PCT/EP2001/010626 WO2002022569A1 (en) | 2000-09-14 | 2001-09-14 | Method for producing chiral compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002212241A1 true AU2002212241A1 (en) | 2002-03-26 |
Family
ID=7656434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002212241A Abandoned AU2002212241A1 (en) | 2000-09-14 | 2001-09-14 | Method for producing chiral compounds |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20030236429A1 (en) |
| EP (1) | EP1317427B1 (en) |
| JP (1) | JP2004509102A (en) |
| KR (1) | KR20030039371A (en) |
| CN (1) | CN1474808A (en) |
| AT (1) | ATE284867T1 (en) |
| AU (1) | AU2002212241A1 (en) |
| BR (1) | BR0113944A (en) |
| CA (1) | CA2422024A1 (en) |
| CZ (1) | CZ2003733A3 (en) |
| DE (2) | DE10045832A1 (en) |
| EC (1) | ECSP034515A (en) |
| ES (1) | ES2234908T3 (en) |
| HK (1) | HK1052923B (en) |
| HU (1) | HUP0302903A3 (en) |
| IL (1) | IL154915A0 (en) |
| MX (1) | MXPA03002253A (en) |
| NO (1) | NO20031137L (en) |
| NZ (1) | NZ524973A (en) |
| PL (1) | PL363012A1 (en) |
| PT (1) | PT1317427E (en) |
| RU (1) | RU2003109607A (en) |
| SK (1) | SK2792003A3 (en) |
| WO (1) | WO2002022569A1 (en) |
| ZA (1) | ZA200302824B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101643383B (en) * | 2008-12-19 | 2012-05-23 | 烟台金正精细化工有限公司 | Preparation method of 1, 1-diphenylethane insulating oil |
| JP2012136466A (en) * | 2010-12-27 | 2012-07-19 | Sumitomo Chemical Co Ltd | Process for producing 2-oxo-4-methylthiobutanoic acid or its salt |
| CN105294519B (en) * | 2015-11-20 | 2017-03-29 | 哈尔滨工业大学(威海) | A kind of synthetic method of the moCys fragments of marine natural productss apratoxin E |
| CN111423332B (en) * | 2020-05-25 | 2023-02-10 | 上海科技大学 | Method for splitting chiral compound |
| CN116655501A (en) * | 2023-05-23 | 2023-08-29 | 岳阳市康利医药化工有限公司 | A kind of optimized synthesis method in the technological process of ethyl isocyanoacetate |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2217706A (en) * | 1988-07-07 | 1989-11-01 | W A Gibbons | alpha -Amino-alkanoic acid derivatives and process for their preparation with anti-inflammatory, analgesic, sedative, hypnotic, anxiolytic, spasmolytic, anaesthetic, muscle relaxant and cardiovascular activity |
-
2000
- 2000-09-14 DE DE10045832A patent/DE10045832A1/en not_active Withdrawn
-
2001
- 2001-09-14 JP JP2002526822A patent/JP2004509102A/en not_active Withdrawn
- 2001-09-14 HK HK03105139.8A patent/HK1052923B/en not_active IP Right Cessation
- 2001-09-14 CN CNA018187021A patent/CN1474808A/en active Pending
- 2001-09-14 PL PL01363012A patent/PL363012A1/en not_active Application Discontinuation
- 2001-09-14 KR KR10-2003-7003777A patent/KR20030039371A/en not_active Withdrawn
- 2001-09-14 BR BR0113944-4A patent/BR0113944A/en not_active IP Right Cessation
- 2001-09-14 HU HU0302903A patent/HUP0302903A3/en unknown
- 2001-09-14 AT AT01980386T patent/ATE284867T1/en not_active IP Right Cessation
- 2001-09-14 CZ CZ2003733A patent/CZ2003733A3/en unknown
- 2001-09-14 AU AU2002212241A patent/AU2002212241A1/en not_active Abandoned
- 2001-09-14 PT PT01980386T patent/PT1317427E/en unknown
- 2001-09-14 EP EP01980386A patent/EP1317427B1/en not_active Expired - Lifetime
- 2001-09-14 RU RU2003109607/04A patent/RU2003109607A/en not_active Application Discontinuation
- 2001-09-14 CA CA002422024A patent/CA2422024A1/en not_active Abandoned
- 2001-09-14 SK SK279-2003A patent/SK2792003A3/en unknown
- 2001-09-14 NZ NZ524973A patent/NZ524973A/en unknown
- 2001-09-14 WO PCT/EP2001/010626 patent/WO2002022569A1/en not_active Ceased
- 2001-09-14 DE DE50104847T patent/DE50104847D1/en not_active Expired - Fee Related
- 2001-09-14 ES ES01980386T patent/ES2234908T3/en not_active Expired - Lifetime
- 2001-09-14 MX MXPA03002253A patent/MXPA03002253A/en unknown
- 2001-09-14 IL IL15491501A patent/IL154915A0/en unknown
-
2003
- 2003-03-12 NO NO20031137A patent/NO20031137L/en unknown
- 2003-03-14 US US10/387,870 patent/US20030236429A1/en not_active Abandoned
- 2003-03-14 EC EC2003004515A patent/ECSP034515A/en unknown
- 2003-04-10 ZA ZA200302824A patent/ZA200302824B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002022569A8 (en) | 2002-06-13 |
| HK1052923A1 (en) | 2003-10-03 |
| CN1474808A (en) | 2004-02-11 |
| WO2002022569A1 (en) | 2002-03-21 |
| CZ2003733A3 (en) | 2003-09-17 |
| ATE284867T1 (en) | 2005-01-15 |
| EP1317427A1 (en) | 2003-06-11 |
| ES2234908T3 (en) | 2005-07-01 |
| MXPA03002253A (en) | 2003-06-24 |
| ZA200302824B (en) | 2004-05-11 |
| JP2004509102A (en) | 2004-03-25 |
| EP1317427B1 (en) | 2004-12-15 |
| DE10045832A1 (en) | 2002-05-29 |
| SK2792003A3 (en) | 2003-10-07 |
| KR20030039371A (en) | 2003-05-17 |
| PL363012A1 (en) | 2004-11-15 |
| BR0113944A (en) | 2004-06-22 |
| IL154915A0 (en) | 2003-10-31 |
| HUP0302903A3 (en) | 2007-05-02 |
| HUP0302903A2 (en) | 2003-12-29 |
| DE50104847D1 (en) | 2005-01-20 |
| NZ524973A (en) | 2005-08-26 |
| ECSP034515A (en) | 2003-04-25 |
| NO20031137D0 (en) | 2003-03-12 |
| HK1052923B (en) | 2005-06-30 |
| RU2003109607A (en) | 2004-10-20 |
| NO20031137L (en) | 2003-05-05 |
| CA2422024A1 (en) | 2003-03-12 |
| US20030236429A1 (en) | 2003-12-25 |
| PT1317427E (en) | 2005-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ337861A (en) | N-heterocyclic derivatives for treating multiple sclerosis, HIV dementia, Parkinson's disease, meningitis, atherosclerosis, cancer, inflammatory skin diseases | |
| WO2001078711A3 (en) | Pde-v inhibitors for treatment of parkinson's disease | |
| WO2005002626A3 (en) | Therapeutic phosphonate compounds | |
| PL345215A1 (en) | Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same | |
| MXPA04004498A (en) | N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation. | |
| MY136269A (en) | Novel diphenylazetidinone, process for its preparation, medicaments comprising this compound and their use | |
| PL364598A1 (en) | Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments | |
| CA2301742A1 (en) | 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2 | |
| YU89402A (en) | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-/2,3'/ bipyridinyl in pure crystalline form and process for synthesis | |
| ZA200404752B (en) | 6-aminomorphinane derivatives method for the production and use thereof | |
| MXPA04002282A (en) | Novel compounds and compositions as cathepsin inhibitors. | |
| UA66792C2 (en) | A method for the preparation of 2-aryl-3-aryl-5-halogenopyridines being used as сох-2 inhibitors | |
| WO2003037863A3 (en) | Substituted indoles, method for production and use thereof for the inhibition of pain | |
| AU2001246999A1 (en) | New neurokinin antagonists for use as medicaments | |
| CA2296560A1 (en) | Amino acid derivatives useful to treat stroke | |
| AU2002212241A1 (en) | Method for producing chiral compounds | |
| AU2002246317A1 (en) | Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof | |
| PL328225A1 (en) | Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors | |
| WO2003080631A8 (en) | Plasma carboxypeptidase b inhibitors | |
| EP1253139A3 (en) | Multioligoanilinated fullerenes | |
| MXPA04005151A (en) | Therapeutic compounds. | |
| ATE267832T1 (en) | SUBSTANCE GM-95, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | |
| CA2301590A1 (en) | 2-aminopyridines as inhibitors of cyclooxygenase-2 | |
| AU2001244999A1 (en) | Naphthamide neurokinin antagonists for use as medicaments | |
| GB0019008D0 (en) | Therapeutic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |